227 related articles for article (PubMed ID: 301776)
1. Regulatory control of tetrahydrofolate coenzymes in folate auxotrophs.
Albrecht AM
Cancer Treat Rep; 1977 Jul; 61(4):533-8. PubMed ID: 301776
[TBL] [Abstract][Full Text] [Related]
2. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
Matherly LH; Barlowe CK; Goldman ID
Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
Whitehead VM
Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
[TBL] [Abstract][Full Text] [Related]
4. Selection and characterization of mutant strains of Streptococcus faecium var. durans resistant to methasquin and amethopterin.
Rader JI; Hutchison DJ
Cancer Res; 1972 Apr; 32(4):688-95. PubMed ID: 5014779
[No Abstract] [Full Text] [Related]
5. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
Zhao R; Babani S; Gao F; Liu L; Goldman ID
Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
[TBL] [Abstract][Full Text] [Related]
6. Depletion of 5,10-methylenetetrahydrofolate and 10-formyltetrahydrofolate by methotrexate in cultured hepatoma cells.
Rhee MS; Coward JK; Galivan J
Mol Pharmacol; 1992 Nov; 42(5):909-16. PubMed ID: 1435754
[TBL] [Abstract][Full Text] [Related]
7. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
FitzGerald GB; Wick MM
Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
[TBL] [Abstract][Full Text] [Related]
8. Induction of the dihydrofolate reductase of Streptococcus faecium var. Durans by folic acid and by some of its derivatives.
Bloch A
Biochim Biophys Acta; 1970 Feb; 201(2):323-33. PubMed ID: 5309275
[No Abstract] [Full Text] [Related]
9. Simultaneous changes in various mechanisms that mediate the cell incorporation of folate compounds account for low levels of resistance to methotrexate.
Cavalcanti F; Calvo N; Grau-Oliete MR; Rivera-Fillat MP
Cell Biochem Funct; 1992 Mar; 10(1):1-7. PubMed ID: 1533575
[TBL] [Abstract][Full Text] [Related]
10. Folate reductase of the amethopterin-resistant Streptococcus faecium var. durans-Ak. I. Inhibition by amethopterin and methasquin, a new quinazoline antifolate.
Albrecht AM; Hutchison DJ
Mol Pharmacol; 1970 Jul; 6(4):323-34. PubMed ID: 4393363
[No Abstract] [Full Text] [Related]
11. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
Goldman ID; Matherly LH
NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654
[TBL] [Abstract][Full Text] [Related]
12. Interaction of methotrexate polyglutamates and dihydrofolate during leucovorin rescue in a human breast cancer cell line (MCF-7).
Allegra CJ; Boarman D
Cancer Res; 1990 Jun; 50(12):3574-8. PubMed ID: 1692762
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
[TBL] [Abstract][Full Text] [Related]
14. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
[TBL] [Abstract][Full Text] [Related]
16. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
Rhee MS; Galivan J; Wright JE; Rosowsky A
Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a localized conversion of endogenous tetrahydrofolate cofactors to dihydrofolate as an important element in antifolate action in murine leukemia cells.
Matherly LH; Muench SP
Biochem Pharmacol; 1990 Jun; 39(12):2005-14. PubMed ID: 2141258
[TBL] [Abstract][Full Text] [Related]
18. Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system.
Fry DW; Besserer JA; Boritzki TJ
Cancer Res; 1984 Aug; 44(8):3366-70. PubMed ID: 6547636
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and pharmacologic rationale for high-dose methotrexate.
Jolivet J
NCI Monogr; 1987; (5):61-5. PubMed ID: 2448656
[TBL] [Abstract][Full Text] [Related]
20. Further studies on the pharmacologic effects of the 7-hydroxy catabolite of methotrexate in the L1210 murine leukemia cell.
Seither RL; Rape TJ; Goldman ID
Biochem Pharmacol; 1989 Mar; 38(5):815-22. PubMed ID: 2467676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
